Unknown

Dataset Information

0

Real‐Life Comparison of Antivirals for SARS‐CoV‐2 Omicron Infection in Patients With Hematologic Malignancies

ABSTRACT:

SUBMITTER: Aiello T 

PROVIDER: S-EPMC10928260 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Activity of AZD7442 (tixagevimab-cilgavimab) against Omicron SARS-CoV-2 in patients with hematologic malignancies.
| S-EPMC9108069 | biostudies-literature
Unknown Effectiveness of Paxlovid in the treatment of the SARS-CoV-2 Omicron variant infection in children with hematologic malignancies: a retrospective cohort study.
| S-EPMC11384919 | biostudies-literature
Unknown Clinical and immunological characteristics of prolonged SARS-CoV-2 Omicron infection in hematologic disease.
| S-EPMC10477167 | biostudies-literature
Unknown Monoclonal Antibodies against SARS-CoV-2 Infection: Results from a Real-Life Study before the Omicron Surge.
| S-EPMC9693092 | biostudies-literature
Unknown Comparison between available early antiviral treatments in outpatients with SARS-CoV-2 infection: a real-life study.
| S-EPMC10546723 | biostudies-literature
Unknown Weak immunogenicity of SARS-CoV-2 vaccine in patients with hematologic malignancies.
| S-EPMC8353615 | biostudies-literature
Unknown Antibody response to SARS-CoV-2 vaccines in patients with hematologic malignancies.
| S-EPMC8295014 | biostudies-literature
Unknown Comparison of different serological assays for SARS-CoV-2 in real life.
| S-EPMC7396207 | biostudies-literature
Unknown Wide Real-Life Data Support Reduced Sensitivity of Antigen Tests for Omicron SARS-CoV-2 Infections.
| S-EPMC11125898 | biostudies-literature
Unknown Outcome of infection with omicron SARS-CoV-2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report.
| S-EPMC9349555 | biostudies-literature